RESUMO
In pasture-based systems, there are nutritional and climatic challenges exacerbated across lactation; thus, dairy cows require an enhanced adaptive capacity compared with cows in confined systems. We aimed to evaluate the effect of lactation stage (21 vs. 180 days in milk, DIM) and Holstein genetic strain (North American Holstein, NAH, n = 8; New Zealand Holstein, NZH, n = 8) on metabolic adaptations of grazing dairy cows through plasma metabolomic profiling and its association with classical metabolites. Although 67 metabolites were affected (FDR < 0.05) by DIM, no metabolite was observed to differ between genetic strains while only alanine was affected (FDR = 0.02) by the interaction between genetic strain and DIM. However, complementary tools for time-series analysis (ASCA analysis, MEBA ranking) indicated that alanine and the branched-chain amino acids (BCAA) differed between genetic strains in a lactation-stage dependent manner. Indeed, NZH cows had lower (P-Tukey < 0.05) plasma concentrations of leucine, isoleucine and valine than NAH cows at 21 DIM, probably signaling for greater insulin sensitivity. Metabolic pathway analysis also revealed that, independently of genetic strains, AA metabolism might be structurally involved in homeorhetic changes as 40% (19/46) of metabolic pathways differentially expressed (FDR < 0.05) between 21 and 180 DIM belonged to AA metabolism.
Assuntos
Aminoácidos de Cadeia Ramificada/sangue , Bovinos/sangue , Bovinos/genética , Lactação/sangue , Leite/química , Ácido 3-Hidroxibutírico/sangue , Alanina/sangue , Animais , Glicemia/metabolismo , Dieta/veterinária , Ácidos Graxos não Esterificados/sangue , Feminino , Insulina/sangue , Metaboloma/genética , Metabolômica/métodos , Ureia/sangueRESUMO
Docosahexaenoic acid (DHA, 22:6n-3) must be consumed in the diet or synthesized from n-3 polyunsaturated fatty acid (PUFA) precursors. However, the effect of dietary DHA on the metabolic pathway is not fully understood. Presently, 21-day-old Long Evans rats were weaned onto one of four dietary protocols: 1) 8 weeks of 2% ALA (ALA), 2) 6 weeks ALA followed by 2 weeks of 2% ALAâ¯+â¯2% DHA (DHA), 3) 4 weeks ALA followed by 4 weeks DHA and 4) 8 weeks of DHA. After the feeding period, 2H5-ALA and 13C20-eicosapentaenoic acid (EPA, 20:5n-3) were co-infused and blood was collected over 3 h for determination of whole-body synthesis-secretion kinetics. The synthesis-secretion coefficient (ml/min, means ± SEM) for EPA (0.238±0.104 vs. 0.021±0.001) and DPAn-3 (0.194±0.060 vs. 0.020±0.008) synthesis from plasma unesterified ALA, and DPAn-3 from plasma unesterified EPA (2.04±0.89 vs. 0.163±0.025) were higher (P<.05) after 2 weeks compared to 8 weeks of DHA feeding. The daily synthesis-secretion rate (nmol/d) of DHA from EPA was highest after 4 weeks of DHA feeding (843±409) compared to no DHA (70±22). Liver gene expression of ELOVL2 and FADS2 were lower (P<.05) after 4 vs. 8 weeks of DHA. Higher synthesis-secretion kinetics after 2 and 4 weeks of DHA feeding suggests an increased throughput of the PUFA metabolic pathway. Furthermore, these findings may lead to novel dietary strategies to maximize DHA levels while minimizing dietary requirements.
Assuntos
Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácidos Graxos Ômega-3/sangue , Alanina/administração & dosagem , Alanina/sangue , Animais , Isótopos de Carbono , Deutério , Suplementos Nutricionais , Ácido Eicosapentaenoico/administração & dosagem , Ácido Eicosapentaenoico/sangue , Ácidos Graxos Ômega-3/biossíntese , Cinética , Fígado/enzimologia , Masculino , RNA Mensageiro/análise , Ratos , Ratos Long-Evans , Fatores de TempoRESUMO
A study was carried out to investigate the effects of dietary methionine source and level on plasma free amino acids patterns and the expression of genes involved in hepatic methionine metabolism in broiler breeders. A total of 2184 broiler breeders were assigned to 13 dietary treatments, with eight replicates per treatment. The 13 treatments included one control group and 12 additional treatments employing two sources and six levels (0.05, 0.10, 0.15, 0.20, 0.25 and 1.00%). Higher plasma methionine concentration was measured for DL-methionine (DLM) treated hens. Plasma alanine concentration was linearly increased as DLM or 2-hydroxy-4-(methylthio) butanoic acid (HMTBA) supplementation level increased. There was a linear increase in concentrations of tyrosine, valine, glycine and serine as dietary DLM supplementation level increased. Hens treated with DLM had higher relative expression of ADA than those fed HMTBA. The expression of MS, ADA, SAHH and MAT2A changed quadratically as HMTBA supplementation level increased, while the expression of GNMT and SAHH changed quadratically as DLM supplementation level increased. In conclusion, the effects of HMTBA on plasma free amino acid patterns and the expression of hepatic genes involved with methionine are different from DLM.
Assuntos
Aminoácidos Sulfúricos/metabolismo , Galinhas/sangue , Galinhas/metabolismo , Dieta/veterinária , Suplementos Nutricionais , Expressão Gênica , Fígado/metabolismo , Metionina/administração & dosagem , Metionina/metabolismo , Adenosina Desaminase , Alanina/sangue , Aminoácidos Sulfúricos/sangue , Animais , Butiratos/administração & dosagem , Feminino , Glicina/sangue , Metionina/sangue , Metionina Adenosiltransferase , Serina/sangue , Tirosina/sangue , Valina/sangueRESUMO
The use of flavonoids as dietary supplements is well established, mainly due to their intense antioxidant and anti-inflammatory properties. In the present study, hesperidin, naringin, and vitamin E were used as additives at different concentrations in poultry rations in order to achieve meat of improved quality. NMR metabolomics was applied to chicken blood serum samples to discern whether and how the enriched rations affected the animals' metabolic profile. Variations in the metabolic patterns according to sustenance consumption were traced by orthogonal projections to latent structures discriminant analysis (OPLS-DA) models and were attributed to specific metabolites by using S-line plots. In particular, serum samples from chickens fed with vitamin E displayed higher concentrations of glycine and succinic acid compared to control samples, which were mainly characterized by betaine, formic acid, and lipoproteins. Samples from chickens fed with hesperidin were characterized by increased levels of lactic acid, citric acid, creatine, carnosine, creatinine, phosphocreatine, anserine, glucose, and alanine compared to control samples. Lastly, naringin samples exhibited increased levels of citric and acetic acids. Results verify the scalability of NMR metabolomics to highlight metabolite variations among chicken serum samples in relation to food rations.
Assuntos
Anti-Inflamatórios/administração & dosagem , Antioxidantes/administração & dosagem , Suplementos Nutricionais , Flavanonas/administração & dosagem , Hesperidina/administração & dosagem , Metabolômica , Vitamina E/administração & dosagem , Ácido 3-Hidroxibutírico/sangue , Ácido Acético/sangue , Alanina/sangue , Ração Animal , Animais , Betaína/sangue , Galinhas , Ácido Cítrico/sangue , Creatina/sangue , Glicina/sangue , Lipoproteínas/sangue , Aves Domésticas , Ácido Succínico/sangueRESUMO
In this study we investigated the chronic effects of oral l-glutamine and l-alanine supplementation, either in their free or dipeptide form, on glutamine-glutathione (GLN-GSH) axis and cytoprotection mediated by HSP-27 in rats submitted to resistance exercise (RE). Forty Wistar rats were distributed into 5 groups: sedentary; trained (CTRL); and trained supplemented with l-alanyl-l-glutamine, l-glutamine and l-alanine in their free form (GLN+ALA), or free l-alanine (ALA). All trained animals were submitted to a 6-week ladder-climbing protocol. Supplementations were offered in a 4% drinking water solution for 21 days prior to euthanasia. Plasma glutamine, creatine kinase (CK), myoglobin (MYO), and erythrocyte concentration of reduced GSH and glutathione disulfide (GSSG) were measured. In tibialis anterior skeletal muscle, GLN-GSH axis, thiobarbituric acid reactive substances (TBARS), and the expression of heat shock factor 1 (HSF-1), 27-kDa heat shock protein (HSP-27), and glutamine synthetase were determined. In CRTL animals, high-intensity RE reduced muscle glutamine levels and increased GSSG/GSH rate and TBARS, as well as augmented plasma CK and MYO levels. Conversely, l-glutamine-supplemented animals showed an increase in plasma and muscle levels of glutamine, with a reduction in GSSG/GSH rate, TBARS, and CK. Free l-alanine administration increased plasma glutamine concentration and lowered muscle TBARS. HSF-1 and HSP-27 were high in all supplemented groups when compared with CTRL (p < 0.05). The results presented herein demonstrate that l-glutamine supplemented with l-alanine, in both a free or dipeptide form, improve the GLN-GSH axis and promote cytoprotective effects in rats submitted to high-intensity RE training.
Assuntos
Alanina/administração & dosagem , Glutamina/administração & dosagem , Glutationa/sangue , Proteínas de Choque Térmico HSP27/metabolismo , Músculo Esquelético/metabolismo , Condicionamento Físico Animal , Alanina/sangue , Animais , Creatina Quinase/sangue , Proteínas de Ligação a DNA/metabolismo , Suplementos Nutricionais , Eritrócitos/citologia , Eritrócitos/metabolismo , Glutamato-Amônia Ligase/metabolismo , Glutamina/sangue , Dissulfeto de Glutationa/sangue , Fatores de Transcrição de Choque Térmico , Masculino , Mioglobina/sangue , Ratos , Ratos Wistar , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Fatores de Transcrição/metabolismoRESUMO
BACKGROUND & AIMS: Branched-chain amino acids promote muscle-protein synthesis, reduce protein oxidation and have positive effects on mitochondrial biogenesis and reactive oxygen species scavenging. The purpose of the study was to determine the potential benefits of branched-chain amino acids supplementation on changes in force capacities, plasma amino acids concentration and muscle metabolic alterations after exercise-induced muscle damage. METHODS: (31)P magnetic resonance spectroscopy and biochemical analyses were used to follow the changes after such damage. Twenty six young healthy men were randomly assigned to supplemented branched-chain amino acids or placebo group. Knee extensors maximal voluntary isometric force was assessed before and on four days following exercise-induced muscle damage. Concentrations in phosphocreatine [PCr], inorganic phosphate [Pi] and pH were measured during a standardized rest-exercise-recovery protocol before, two (D2) and four (D4) days after exercise-induced muscle damage. RESULTS: No significant difference between groups was found for changes in maximal voluntary isometric force (-24% at D2 and -21% at D4). Plasma alanine concentration significantly increased immediately after exercise-induced muscle damage (+25%) in both groups while concentrations in glycine, histidine, phenylalanine and tyrosine decreased. No difference between groups was found in the increased resting [Pi] (+42% at D2 and +34% at D4), decreased resting pH (-0.04 at D2 and -0.03 at D4) and the slower PCr recovery rate (-18% at D2 and -24% at D4). CONCLUSIONS: The damaged muscle was not able to get benefits out of the increased plasma branched-chain amino acids availability to attenuate changes in indirect markers of muscle damage and muscle metabolic alterations following exercise-induced muscle damage.
Assuntos
Aminoácidos de Cadeia Ramificada/administração & dosagem , Aminoácidos de Cadeia Ramificada/sangue , Suplementos Nutricionais , Músculo Esquelético/efeitos dos fármacos , Adulto , Alanina/sangue , Índice de Massa Corporal , Peso Corporal , Método Duplo-Cego , Exercício Físico , Glicina/sangue , Histidina/sangue , Humanos , Concentração de Íons de Hidrogênio , Joelho/fisiologia , Espectroscopia de Ressonância Magnética , Masculino , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Fenilalanina/sangue , Fosfatos/sangue , Fosfocreatina/sangue , Tirosina/sangue , Adulto JovemRESUMO
BACKGROUND AND OBJECTIVES: Chinese herbal drug Da-Cheng-Qi decoction (DCQD) has been widely used for decades to treat acute pancreatitis (AP). Previous trials are mostly designed to state the potential mechanisms of the therapeutic effects rather than to detect its whole effect on metabolism. This study aimed to investigate the efficacy of DCQD on metabolism in AP. METHODS: Twenty-two male adult Sprague-Dawley rats were randomized into three groups. AP was induced by retrograde ductal infusion of 3.5% sodium taurocholate solution in DCQD and AP group, while 0.9% saline solution was used in sham operation (SO) group. Blood samples were obtained 12 h after drug administration and a 600 MHz superconducting Nuclear Magnetic Resonance (NMR) spectrometer was used to detected plasma metabolites. Principal Components Analysis (PCA) and Partial Least Squares-Discriminant Analysis after Orthogonal Signal Correction (OSC-PLS-DA) were applied to analyze the Longitudinal Eddy-delay (LED) and Carr-Purcell-Meiboom-Gill (CPMG) spectra. RESULTS: Differences in concentrations of metabolites among the three groups were detected by OSC-PLS-DA of 1HNMR spectra (both LED and CPMG). Compared with SO group, DCQD group had higher levels of plasma glycerol, glutamic acid, low density lipoprotein (LDL), saturated fatty acid (FA) and lower levels of alanine and glutamine, while the metabolic changes were reversed in the AP group. CONCLUSIONS: Our results demonstrated that DCQD was capable of altering the changed concentrations of metabolites in rats with AP and 1HNMR-based metabolomic approach provided a new methodological cue for systematically investigating the efficacies and mechanisms of DCQD in treating AP.
Assuntos
Medicamentos de Ervas Chinesas/farmacocinética , Medicamentos de Ervas Chinesas/uso terapêutico , Pancreatite/tratamento farmacológico , Pancreatite/metabolismo , Alanina/sangue , Animais , Biotransformação , LDL-Colesterol/sangue , Ácidos Graxos/sangue , Ácido Glutâmico/sangue , Glutamina/sangue , Glicerol/sangue , Espectroscopia de Ressonância Magnética , Masculino , Metabolômica , Ratos , Ratos Sprague-DawleyRESUMO
This study was conducted with a swine model to determine the safety of long-term dietary supplementation with L-arginine-HCl or L-arginine free base. Beginning at 30 days of age, pigs were fed a corn- and soybean meal-based diet (31.5 g/kg body weight/day) supplemented with 0, 1.21, 1.81 or 2.42 % L-arginine-HCl (Experiment 1) or with 0, 1, 1.5 or 2 % L-arginine (Experiment 2). The supplemental doses of 0, 1, 1.5, and 2 % L-arginine provided pigs with 0, 315, 473, and 630 mg L-arginine/kg body weight/day, respectively, which were equivalent to 0, 286, 430, and 573 mg L-arginine/kg body weight/day, respectively, in humans. At 121 days of age (91 days after initiation of supplementation), blood samples were obtained from the jugular vein of pigs at 1 and 4 h after feeding for hematological and clinical chemistry tests. Dietary supplementation with L-arginine increased plasma concentrations of arginine, ornithine, proline, albumin and reticulocytes, while reducing plasma concentrations of ammonia, free fatty acids, triglyceride, cholesterol, and neutrophils. L-Arginine supplementation enhanced protein gain and reduced white-fat deposition in the body. Other variables in standard hematology and clinical chemistry tests, serum concentrations of insulin, growth hormone and insulin-like growth factor-I did not differ among all the groups of pigs. These results indicate that dietary supplementation with L-arginine (up to 630 mg/kg body weight/day) is safe in pigs for at least 91 days. Our findings help guide clinical studies to determine the safety of long-term oral administration of L-arginine to humans.
Assuntos
Tecido Adiposo Branco/efeitos dos fármacos , Arginina/administração & dosagem , Composição Corporal/efeitos dos fármacos , Suplementos Nutricionais , Músculo Esquelético/efeitos dos fármacos , Tecido Adiposo Branco/metabolismo , Alanina/sangue , Amônia/sangue , Animais , Animais Lactentes , Arginina/sangue , Colesterol/sangue , Feminino , Glutamina/sangue , Glicina/sangue , Masculino , Músculo Esquelético/metabolismo , Ornitina/sangue , Prolina/sangue , Suínos , Fatores de Tempo , Triglicerídeos/sangue , DesmameRESUMO
INTRODUCTION: Low plasma glutamine levels are associated with worse clinical outcome. Intravenous glutamine infusion dose- dependently increases plasma glutamine levels, thereby correcting hypoglutaminemia. Glutamine may be transformed to glutamate which might limit its application at a higher dose in patients with severe traumatic brain injury (TBI). To date, the optimal glutamine dose required to normalize plasma glutamine levels without increasing plasma and cerebral glutamate has not yet been defined. METHODS: Changes in plasma and cerebral glutamine, alanine, and glutamate as well as indirect signs of metabolic impairment reflected by increased intracranial pressure (ICP), lactate, lactate-to-pyruvate ratio, electroencephalogram (EEG) activity were determined before, during, and after continuous intravenous infusion of 0.75 g L-alanine-L-glutamine which was given either for 24 hours (group 1, n = 6) or 5 days (group 2, n = 6) in addition to regular enteral nutrition. Lab values including nitrogen balance, urea and ammonia were determined daily. RESULTS: Continuous L-alanine-L-glutamine infusion significantly increased plasma and cerebral glutamine as well as alanine levels, being mostly sustained during the 5 day infusion phase (plasma glutamine: from 295 ± 62 to 500 ± 145 µmol/ l; brain glutamine: from 183 ± 188 to 549 ± 120 µmol/ l; plasma alanine: from 327 ± 91 to 622 ± 182 µmol/ l; brain alanine: from 48 ± 55 to 89 ± 129 µmol/ l; p < 0.05, ANOVA, post hoc Dunn's test). CONCLUSIONS: High dose L-alanine-L-glutamine infusion (0.75 g/ kg/ d up to 5 days) increased plasma and brain glutamine and alanine levels. This was not associated with elevated glutamate or signs of potential glutamate-mediated cerebral injury. The increased nitrogen load should be considered in patients with renal and hepatic dysfunction. TRIAL REGISTRATION: Clinicaltrials.gov NCT02130674. Registered 5 April 2014.
Assuntos
Alanina/administração & dosagem , Lesões Encefálicas/tratamento farmacológico , Lesões Encefálicas/metabolismo , Ácido Glutâmico/metabolismo , Glutamina/administração & dosagem , Índice de Gravidade de Doença , Adolescente , Adulto , Alanina/sangue , Alanina/metabolismo , Lesões Encefálicas/diagnóstico , Dipeptídeos/administração & dosagem , Dipeptídeos/sangue , Dipeptídeos/metabolismo , Feminino , Ácido Glutâmico/sangue , Glutamina/sangue , Glutamina/metabolismo , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
BACKGROUND: Green tea catechins have been hypothesized to increase energy expenditure and fat oxidation by inhibiting catechol-O-methyltransferase (COMT) and thus promoting more sustained adrenergic stimulation. Metabolomics may help to clarify the mechanisms underlying their putative physiological effects. OBJECTIVE: The study investigated the effects of 7-day ingestion of green tea extract (GTE) on the plasma metabolite profile at rest and during exercise. METHODS: In a placebo-controlled, double-blind, randomized, parallel study, 27 healthy physically active males consumed either GTE (n=13, 1200 mg catechins, 240 mg caffeine/day) or placebo (n=14, PLA) drinks for 7 days. After consuming a final drink (day 8), they rested for 2 h and then completed 60 min of moderate-intensity cycling exercise (56% ± 4% VO(2)max). Blood samples were collected before and during exercise. Plasma was analyzed using untargeted four-phase metabolite profiling and targeted profiling of catecholamines. RESULTS: Using the metabolomic approach, we observed that GTE did not enhance adrenergic stimulation (adrenaline and noradrenaline) during rest or exercise. At rest, GTE led to changes in metabolite concentrations related to fat metabolism (3-ß-hydroxybutyrate), lipolysis (glycerol) and tricarboxylic acid cycle (TCA) cycle intermediates (citrate) when compared to PLA. GTE during exercise caused reductions in 3-ß-hydroxybutyrate concentrations as well as increases in pyruvate, lactate and alanine concentrations when compared to PLA. CONCLUSIONS: GTE supplementation resulted in marked metabolic differences during rest and exercise. Yet these metabolic differences were not related to the adrenergic system, which questions the in vivo relevance of the COMT inhibition mechanism of action for GTE.
Assuntos
Camellia sinensis , Metabolismo Energético/efeitos dos fármacos , Exercício Físico/fisiologia , Lipólise/efeitos dos fármacos , Extratos Vegetais/farmacologia , Descanso , Ácido 3-Hidroxibutírico/metabolismo , Adolescente , Adulto , Alanina/sangue , Catecolaminas/sangue , Método Duplo-Cego , Epinefrina/sangue , Glicerol/metabolismo , Humanos , Lactatos/sangue , Masculino , Metabolômica , Norepinefrina/sangue , Chá , Adulto JovemRESUMO
Leigh syndrome (LS) is a progressive untreatable degenerating mitochondrial disorder caused by either mitochondrial or nuclear DNA mutations. A patient was a second child of unconsanguineous parents. On the third day of birth, he was transferred to neonatal intensive care units because of severe lactic acidosis. Since he was showing continuous lactic acidosis, the oral supplementation of dichloroacetate (DCA) was introduced on 31st day of birth at initial dose of 50 mg/kg, followed by maintenance dose of 25 mg/kg/every 12 h. The patient was diagnosed with LS due to a point mutation of an A-C at nucleotide 599 in exon 6 in the pyruvate dehydrogenase E1α gene, resulting in the substitution of aspartate for threonine at position 200 (N200T). Although the concentrations of lactate and pyruvate in blood were slightly decreased, his clinical conditions were deteriorating progressively. In order to overcome the mitochondrial or cytosolic energy crisis indicated by lactic acidosis as well as clinical symptoms, we terminated the DCA and administered 0.5 g/kg/day TID of sodium pyruvate orally. We analyzed the therapeutic effects of DCA or sodium pyruvate in the patient, and found that pyruvate therapy significantly decreased lactate, pyruvate and alanine levels, showed no adverse effects such as severe neuropathy seen in DCA, and had better clinical response on development and epilepsy. Though the efficacy of pyruvate on LS will be evaluated by randomized double-blind placebo-controlled study design in future, pyruvate therapy is a possible candidate for therapeutic choice for currently incurable mitochondrial disorders such as LS.
Assuntos
Ácido Dicloroacético/uso terapêutico , Doença de Leigh/tratamento farmacológico , Doença de Leigh/genética , Mutação/genética , Piruvato Desidrogenase (Lipoamida)/genética , Ácido Pirúvico/uso terapêutico , Alanina/sangue , Células Cultivadas , Pré-Escolar , Eletroencefalografia , Fibroblastos/enzimologia , Humanos , Ácido Láctico/sangue , Doença de Leigh/fisiopatologia , Masculino , Ácido Pirúvico/sangue , Ácido Pirúvico/líquido cefalorraquidiano , Estatísticas não ParamétricasRESUMO
Physical exercise affects hematological equilibrium and metabolism. This study evaluated the biochemical and hematological responses of a male world-class athlete in sailing who is ranked among the top athletes on the official ISAF ranking list of windsurfing, class RS:X. The results describe the metabolic adaptations of this athlete in response to exercise in two training situations: the first when the athlete was using the usual training and dietary protocol, and the second following training and nutritional interventions based on a careful analysis of his diet and metabolic changes measured in a simulated competition. The intervention protocol for this study consisted of a 3-month facility-based program using neuromuscular training (NT), aerobic training (AT), and nutritional changes to promote anabolism and correct micronutrient malnutrition. Nutritional and training intervention produced an increase in the plasma availability of branched-chain amino acids (BCAAs), aromatic amino acids (AAAs), alanine, glutamate, and glutamine during exercise. Both training and nutritional interventions reduced ammonemia, uricemia, and uremia. In addition, we are able to correct a significant drop in potassium levels during races by correct supplementation. Due to the uniqueness of this experiment, these results may not apply to other windsurfers, but we nonetheless had the opportunity to characterize the metabolic adaptations of this athlete. We also proposed the importance of in-field metabolic analyses to the understanding, support, and training of world-class elite athletes.
Assuntos
Atletas , Exercício Físico , Esforço Físico , Alanina/sangue , Aminoácidos Aromáticos/sangue , Aminoácidos de Cadeia Ramificada/sangue , Amônia/sangue , Análise Química do Sangue , Glicemia , Creatina Quinase/sangue , Creatinina/sangue , Dieta , Suplementos Nutricionais , Ácido Glutâmico/sangue , Glutamina/sangue , Humanos , Insulina/sangue , L-Lactato Desidrogenase/sangue , Contagem de Leucócitos , Masculino , Análise Multivariada , Fosfatos/sangue , Potássio/sangue , Estresse Fisiológico , Ureia/sangueRESUMO
Alzheimer's disease (AD) poses a serious public health threat to the United States. Disease-modifying drugs slowing AD progression are in urgent need, but they are still unavailable. According to the amyloid cascade hypothesis, inhibition of ß- or γ-secretase, key enzymes for the production of amyloid ß (Aß), may be viable mechanisms for the treatment of AD. For the discovery of γ-secretase inhibitors (GSIs), the APP-overexpressing Tg2576 mouse has been the preclinical model of choice, in part because of the ease of detection of Aß species in its brain, plasma, and cerebrospinal fluid (CSF). Some biological observations and practical considerations, however, argue against the use of the Tg2576 mouse. We reasoned that an animal model would be suitable for GSI discovery if the pharmacokinetic (PK)/pharmacodynamic (PD) relationship of a compound for Aß lowering in this model is predictive of that in human. In this study, we assessed whether the background 129/SVE strain is a suitable preclinical pharmacology model for identifying new GSIs by evaluating the translatability of the intrinsic PK/PD relationships for brain and CSF Aß across the Tg2576 and 129/SVE mouse and human. Using semimechanistically based PK/PD modeling, our analyses indicated that the intrinsic PK/PD relationship for brain Aßx-42 and CSF Aßx-40 in the 129/SVE mouse is indicative of that for human CSF Aß. This result, in conjunction with practical considerations, strongly suggests that the 129/SVE mouse is a suitable model for GSI discovery. Concurrently, the necessity and utilities of PK/PD modeling for rational interpretation of Aß data are established.
Assuntos
Alanina/análogos & derivados , Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Peptídeos beta-Amiloides/metabolismo , Azepinas/farmacologia , Descoberta de Drogas , Inibidores Enzimáticos/farmacologia , Oxidiazóis/farmacologia , Sulfonamidas/farmacologia , Alanina/sangue , Alanina/farmacocinética , Alanina/farmacologia , Secretases da Proteína Precursora do Amiloide/metabolismo , Peptídeos beta-Amiloides/sangue , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Azepinas/sangue , Azepinas/farmacocinética , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/sangue , Inibidores Enzimáticos/farmacocinética , Humanos , Camundongos , Camundongos da Linhagem 129 , Camundongos Transgênicos , Modelos Animais , Oxidiazóis/sangue , Oxidiazóis/farmacocinética , Bibliotecas de Moléculas Pequenas , Sulfonamidas/sangue , Sulfonamidas/farmacocinéticaRESUMO
Obesity is a major health crisis worldwide and new treatments are needed to fight this epidemic. Using the swine model, we recently reported that dietary L-arginine (Arg) supplementation promotes muscle gain and reduces body-fat accretion. The present study tested the hypothesis that Arg regulates expression of key genes involved in lipid metabolism in skeletal muscle and white adipose tissue. Sixteen 110-day-old barrows were fed for 60 days a corn- and soybean-meal-based diet supplemented with 1.0% Arg or 2.05% L-alanine (isonitrogenous control). Blood samples, longissimus dorsi muscle and overlying subcutaneous adipose tissue were obtained from 170-day-old pigs for biochemical studies. Serum concentrations of leptin, alanine and glutamine were lower, but those for Arg and proline were higher in Arg-supplemented pigs than in control pigs. The percentage of oleic acid was higher but that of stearic acid and linoleic acid was lower in muscle of Arg-supplemented pigs, compared with control pigs. Dietary Arg supplementation increased mRNA levels for fatty acid synthase in muscle, while decreasing those for lipoprotein lipase, glucose transporter-4, and acetyl-coenzyme A carboxylase-α in adipose tissue. Additionally, mRNA levels for hormone sensitive lipase were higher in adipose tissue of Arg-supplemented pigs compared with control pigs. These results indicate that Arg differentially regulates expression of fat-metabolic genes in skeletal muscle and white adipose tissue, therefore favoring lipogenesis in muscle but lipolysis in adipose tissue. Our novel findings provide a biochemical basis for explaining the beneficial effect of Arg in improving the metabolic profile in mammals (including obese humans).
Assuntos
Tecido Adiposo Branco/efeitos dos fármacos , Arginina/administração & dosagem , Suplementos Nutricionais , Músculo Esquelético/efeitos dos fármacos , Obesidade/metabolismo , Acetil-CoA Carboxilase/análise , Tecido Adiposo Branco/metabolismo , Alanina/sangue , Animais , Arginina/metabolismo , Fenômenos Químicos , Transportador de Glucose Tipo 4/análise , Glutamina/sangue , Leptina/sangue , Ácido Linoleico/análise , Metabolismo dos Lipídeos , Lipogênese/efeitos dos fármacos , Lipólise , Lipase Lipoproteica/análise , Masculino , Músculo Esquelético/metabolismo , RNA Mensageiro/análise , Ácidos Esteáricos/análise , SuínosRESUMO
BACKGROUND AND AIMS: Studies evaluating the effect of arginine supplementation in human wound healing are inhomogeneous with conflicting results. This study aims to clarify the role of arginine supplementation in the healing of human skin graft donor sites. METHODS: 35 subjects undergoing skin autografting were randomly assigned to receive intravenous arginine (n = 16) or placebo (n = 19) for 5 days in a dose of 30 g of arginine or an isovolumetric amount of placebo (25.2g of alanine). Wound healing was evaluated at the donor sites by objectifying angiogenesis, reepithelialization and neutrophil influx. Plasma amino acid concentrations were measured to evaluate our intervention. RESULTS: The two groups were comparable in age, morbidity and nutritional, metabolic and inflammatory state. Plasma arginine and alanine levels increased significantly upon supplementation in the two groups, respectively. No differences were found between the arginine supplementation group and the placebo group in the studied parameters. Placebo vs. arginine; mean ± SD: neutrophil influx on day 2: 6.67 ± 3.0 vs. 6.57 ± 3.3, p = 0.66; angiogenesis on day 10: 8.0 ± 2.8 vs. 8.9 ± 3.1; reepithelialization in % on day 10: 81 ± 8.5 vs. 85 ± 7.1. CONCLUSION: Intravenous arginine supplementation does not improve angiogenesis, reepithelialization or neutrophil influx in healing of human skin graft donor sites.
Assuntos
Arginina/farmacologia , Queimaduras/tratamento farmacológico , Transplante de Pele , Cicatrização/efeitos dos fármacos , Adulto , Alanina/sangue , Arginina/sangue , Queimaduras/patologia , Queimaduras/cirurgia , Método Duplo-Cego , Feminino , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Neovascularização Fisiológica , Pele/irrigação sanguíneaRESUMO
We previously demonstrated that beta-alanyl-branched chain amino acids have excitatory effects. Therefore, we named beta-alanyl-L-leucine, beta-alanyl-L-isoleucine and beta-alanyl-L-valine as Excitin-1, -2, and -3 , respectively. Since there is little known about the effects of Excitins, we clarified whether oral administration of Excitin-1 affects behavior in rats, alters the monoamine and amino acid levels in the central nervous system, whether Excitin-1 is incorporated into the brain, and how long it remains in the blood. Excitin-1 increased motor behavior, increasing the distance of path and number of rearings in the open field. Excitin-1 influenced some monoamine and amino acid levels in the cerebral cortex and hypothalamus. Following oral administration, Excitin-1 was detected in the cerebral cortex, hypothalamus, hippocampus and olfactory bulb. In the plasma, Excitin-1 and its metabolites beta-alanine and L-leucine were recorded. The present study demonstrated that Excitin-1 was incorporated in the brain and promoted behavioral changes in rats.
Assuntos
Aminoácidos/metabolismo , Comportamento Animal/fisiologia , Encéfalo/metabolismo , Dipeptídeos/farmacologia , Administração Oral , Alanina/administração & dosagem , Alanina/sangue , Alanina/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Dipeptídeos/administração & dosagem , Dipeptídeos/sangue , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Leucina/administração & dosagem , Leucina/sangue , Leucina/farmacologia , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Bulbo Olfatório/efeitos dos fármacos , Bulbo Olfatório/metabolismo , RatosRESUMO
The influence of alanine on plasma amino acid concentrations and fuel substrates as well as cycling performance was examined. Four solutions [6% alanine (ALA); 6% sucrose (CHO); 6% alanine and 6% sucrose (ALA-CHO); an artificially sweetened placebo (PLC)] were tested using a double-blind, randomised, cross-over design. During each trial, ten cyclists ingested 500 mL of test solution 30 min before exercise and 250 mL after 15, 30, and 45 min of exercise. Participants cycled for 45 min at 75% VO(2)max followed by a 15-min performance trial. Blood was collected before beverage consumption and prior to the performance trial. Alanine concentration was increased (p < 0.05) by approximately tenfold for ALA and ALA-CHO and less than twofold for CHO and PLC. Alanine ingestion increased concentrations of most gluconeogenic amino acids. Overall, alanine supplementation tended to produce favourable metabolic effects, but did not influence performance.
Assuntos
Alanina/administração & dosagem , Aminoácidos/sangue , Desempenho Atlético , Ciclismo/fisiologia , Metabolismo Energético/efeitos dos fármacos , Teste de Esforço/efeitos dos fármacos , Adulto , Alanina/sangue , Estudos Cross-Over , Sacarose Alimentar/farmacologia , Suplementos Nutricionais , Método Duplo-Cego , Ingestão de Alimentos , Feminino , Gluconeogênese/efeitos dos fármacos , Gluconeogênese/fisiologia , Humanos , MasculinoRESUMO
In a previous study, the ability of gas chromatography time-of-flight mass spectrometry to detect potential metabolic biomarkers in preeclampsia was demonstrated. In this study, the authors sought to validate their preliminary findings in an entirely different patient cohort using a complementary, novel, and powerful combination of analytical tools (ultra performance liquid chromatography and LTQ Orbitrap mass spectrometry system). Eight metabolites that appeared in the authors' previous patient cohort were identified as being statistically significant (P < .01) as discriminatory biomarkers. The chemical identities of these 8 metabolites were established using authentic chemical standards. They included uric acid, 2-oxoglutarate, glutamate, and alanine. This is the first study to identify, in an unbiased manner, a series of small-molecular-weight metabolites that effectively detect preeclampsia in plasma. The identity of these metabolites provides new insights into the pathology of this condition and raises the possibility of the development of a predictive test.
Assuntos
Pré-Eclâmpsia/sangue , Alanina/sangue , Biomarcadores/sangue , Estudos de Coortes , Feminino , Ácido Glutâmico/sangue , Humanos , Recém-Nascido , Ácidos Cetoglutáricos/sangue , Pré-Eclâmpsia/diagnóstico , Gravidez , Distribuição Aleatória , Ácido Úrico/sangueRESUMO
The hepatoprotective effects of whey protein on two injections of D-galactosamine (300 mg/kg, i.p.) were investigated in rats fed a modified AIN-93M diet formulated with a protein source of casein or whey for 16 d. The whey protein-containing diet clearly suppressed an increase in plasma alanine and aspartate aminotransferase activity, lactate dehydrogenase and bilirubin, which are hepatitis markers, and also hyaluronic acid, a fibrosis marker. In addition, it suppressed histopathological signs of portal fibrosis, bile duct proliferation, and perivenular sclerosis. These results suggest that supplementation with whey protein can help prevent the development of hepatitis and portal fibrosis.
Assuntos
Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Alimentos Formulados , Cirrose Hepática/prevenção & controle , Proteínas do Leite/administração & dosagem , Substâncias Protetoras/administração & dosagem , Alanina/sangue , Animais , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Doença Hepática Induzida por Substâncias e Drogas/patologia , Dieta , Galactosamina/toxicidade , Ácido Hialurônico/sangue , L-Lactato Desidrogenase/sangue , Cirrose Hepática/induzido quimicamente , Cirrose Hepática/patologia , Masculino , Ratos , Ratos Sprague-Dawley , Proteínas do Soro do LeiteRESUMO
Chard (Beta vulgaris L. var cicla) is one of the medicinal herbs used by diabetics in Turkey. It has been reported to reduce blood glucose. We have investigated the effect of chard extracts on the liver by biochemical and morphological investigation. The plant extract was administered by the gavage technique to rats at a dose of 2 g/kg every d for 28 d, 14 d after experimental animals were made diabetic. In the diabetic group, some degenerative changes were observed by light and electron microscope examination, but degenerative changes decreased or were not observed in the diabetic group given chard. In the diabetic group, blood glucose levels, serum alanine, aspartate transaminase, alkaline phosphatase activities, total lipids, sialic and uric acid levels, liver lipid peroxidation (LPO), and nonenzymatic glycosylation (NEG) levels increased, while blood glutathione, body weight, and liver glutathione (GSH) levels decreased. The diabetic group given chard, serum alanine, aspartate transaminase, alkaline phosphatase activities, total lipid level, sialic and uric acid levels, blood glucose levels, and liver LPO and NEG levels decreased, but the other values increased. As a result of all the morphological and biochemical findings obtained, it was concluded that the extract of this plant has a protective effect on the liver in diabetes mellitus.